RAS P21 EXPRESSION IN RELATION TO HISTOPATHOLOGICAL VARIABLES AND PROGNOSIS IN COLORECTAL ADENOCARCINOMA

被引:11
作者
SUN, XF
HATSCHEK, T
WINGREN, S
STAL, O
CARSTENSEN, JM
ZHANG, H
BOERYD, B
SJODAHL, R
NORDENSKJOLD, B
机构
[1] LINKOPING UNIV HOSP,DEPT PATHOL,S-58185 LINKOPING,SWEDEN
[2] LINKOPING UNIV HOSP,DEPT SURG,S-58185 LINKOPING,SWEDEN
关键词
RAS P21; HISTOPATHOLOGY; PROGNOSIS; COLORECTAL ADENOCARCINOMA; IMMUNOHISTOCHEMISTRY;
D O I
10.3109/02841869109088246
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Ras gene protein products (p21) reacting with the monoclonal antibodies ras 11, DWP, R256 and E184 were studied with an immunohistochemical method which was applied to 17 normal and 79 colorectal adenocarcinoma specimens. Normal colorectal epithelium showed positive staining for ras 11 in 35% of the cases, but not for DWP, R256 and E184. The antibodies showed positive staining in colorectal adenocarcinomas in 76, 53, 29 and 35% of the cases respectively. The degree of staining for ras 11 was significantly related to the grade of differentiation and increased from Dukes stage A to C. Strong staining for ras 11 predicted a significantly shorter recurrence-free interval (p < 0.001). In Cox's regression analysis, the degree of staining for ras 11 was a prognostic factor independent of the grade of differentiation and Dukes stage (p < 0.01). The results indicate that the enhanced expression of pan ras p21 may provide an important biological marker for determining prognosis in colorectal adenocarcinomas.
引用
收藏
页码:933 / 939
页数:7
相关论文
共 50 条
  • [1] EXPRESSION OF SMG P21A AND RAS P21 IN EPIDERMAL NEOPLASMS
    MORI, O
    HACHISUKA, H
    SASAI, Y
    SHIKU, H
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 1993, 285 (07) : 441 - 443
  • [2] EXPRESSION OF RAS P21 PROTEIN BY THYMOMA
    MUKAI, K
    SATO, Y
    HIROHASHI, S
    SHIMOSATO, Y
    VIRCHOWS ARCHIV B-CELL PATHOLOGY INCLUDING MOLECULAR PATHOLOGY, 1990, 59 (01) : 11 - 16
  • [3] RAS P21 EXPRESSION IN NEUROBLASTOMAS AND GANGLIO-NEUROBLASTOMAS - CORRELATION WITH PATIENTS PROGNOSIS
    SPANDIDOS, DA
    ARVANITIS, D
    FIELD, JK
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1992, 1 (01) : 53 - 58
  • [4] Immunohistochemical detection of ras p21 expression in pancreatic adenocarcinoma and its clinicopathological significance
    胡育新
    许国铭
    Journal of Medical Colleges of PLA, 1993, (04) : 360 - 362
  • [5] Immunohistochemical analysis of p53 and ras p21 expression in colorectal adenomas and early carcinomas
    Ieda, S
    Watatani, M
    Yoshida, T
    Kuroda, K
    Inui, H
    Yasutomi, M
    SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY, 1996, 26 (04): : 230 - 235
  • [6] Expression of ras p21 in the stromal cells of human neoplastic endometrium
    Miturski, R
    Semczuk, A
    Jakowicki, JA
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 1998, 19 (03) : 308 - 311
  • [7] RAP1 P21 REGULATES THE INTERACTION OF RAS P21 WITH RGL, A NEW EFFECTOR PROTEIN OF RAS P21
    IKEDA, M
    KOYAMA, S
    OKAZAKI, M
    DOHI, K
    KIKUCHI, A
    FEBS LETTERS, 1995, 375 (1-2) : 37 - 40
  • [8] Expression of p27, p21, and p16 protein in early squamous cervical cancer and its relation to prognosis
    Van de Putte, G
    Holm, R
    Lie, AK
    Tropé, CG
    Kristensen, GB
    GYNECOLOGIC ONCOLOGY, 2003, 89 (01) : 140 - 147
  • [9] Ras p21 protein immunoreactivity and its relationship to p53 expression and prognosis in gallbladder and extrahepatic biliary carcinoma
    Lee, CS
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 1997, 23 (03): : 233 - 237
  • [10] p53 expression, p21 expression and the apoptotic index in endometrioid endometrial adenocarcinoma
    Burton, JL
    Stewart, RL
    Heatley, MK
    Royds, JA
    Wells, M
    HISTOPATHOLOGY, 1999, 35 (03) : 221 - 229